| Autor: |
Zhang D; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. zhang_deyi@lilly.com, Kohlman D, Krushinski J, Liang S, Ying BP, Reilly JE, Dinn SR, Wainscott DB, Nutter S, Gough W, Nelson DL, Schaus JM, Xu YC |
| Jazyk: |
angličtina |
| Zdroj: |
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2004 Dec 20; Vol. 14 (24), pp. 6011-6. |
| DOI: |
10.1016/j.bmcl.2004.09.079 |
| Abstrakt: |
Several fused bicyclic systems have been investigated to serve as the core structure of potent and selective 5-HT1F receptor agonists. Replacement of the indole nucleus in 2 with indazole and 'inverted' indazole provided more potent and selective 5-HT1F receptor ligands. Indoline and 1,2-benzisoxazole systems also provided potent 5-HT1F receptor agonists, and the 5-HT1A receptor selectivity of the indoline- and 1,2-benzisoxazole-based 5-HT1F receptor agonists could be improved with modification of the benzoyl moiety of the benzamides. Through these studies, we found that the inherent geometries of the templates, not the nature of hybridization of the linking atom, were important for the 5-HT1F receptor recognition. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect